China's Cyberspace Administration proposed a key follow-on provision to the country's Cybersecurity Law which could directly impact the medical device and biopharma industry.
The draft, Key Information Infrastructure Protection decree, was open for public comments through Aug. 10.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?